Clinical Trial Update: Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating potassium-magnesium citrate as a blood pressure–lowering agent in prehypertensive and hypertensive patients has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Prehypertension

Drugs mentioned

• Potassium Magnesium Citrate (potassium magnesium citrate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pre-hypertension, Hypertension | Phase 1, Phase 2 | Status: WITHDRAWN